Adicet Bio Inc [ACET] stock is trading at $1.24, up 0.81%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ACET shares have gain 2.48% over the last week, with a monthly amount drifted -7.46%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Adicet Bio Inc [NASDAQ: ACET] stock has seen the most recent analyst activity on June 27, 2023, when JMP Securities downgraded its rating to a Mkt Perform. Previously, Guggenheim downgraded its rating to Neutral on June 27, 2023. On June 01, 2023, downgrade downgraded it’s rating to Neutral and revised its price target to $6 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $23 on September 21, 2022. SMBC Nikko initiated its recommendation with a Outperform and recommended $28 as its price target on March 31, 2022. Truist started tracking with a Buy rating for this stock on March 08, 2022, and assigned it a price target of $30. In a note dated March 04, 2022, Jefferies initiated an Buy rating and provided a target price of $27 on this stock.
Adicet Bio Inc [ACET] stock has fluctuated between $1.05 and $3.77 over the past year. Currently, Wall Street analysts expect the stock to reach $32.5 within the next 12 months. Adicet Bio Inc [NASDAQ: ACET] shares were valued at $1.24 at the most recent close of the market. An investor can expect a potential return of 2520.97% based on the average ACET price forecast.
Analyzing the ACET fundamentals
Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -11.6%, Pretax Profit Margin comes in at -10.84%, and Net Profit Margin reading is -10.84%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.65 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1800 points at the first support level, and at 1.1200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2800, and for the 2nd resistance point, it is at 1.3200.
Ratios To Look Out For
For context, Adicet Bio Inc’s Current Ratio is 14.34. In addition, the Quick Ratio stands at 14.34 and the Cash Ratio stands at 14.18.
Transactions by insiders
Recent insider trading involved Kauffman Michael, Director, that happened on Jun 05 ’24 when 5900.0 shares were sold. Director, ORBIMED ADVISORS LLC completed a deal on Jan 25 ’24 to buy 3.12 million shares. Meanwhile, Director GORDON CARL L bought 3.12 million shares on Jan 25 ’24.
